Influence of different proton pump inhibitors on the pharmacokinetics of voriconazole
Authors:
- 1 April 2017
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 49 (4) , 403-409
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coliMicrobial Cell Factories, 2016
- In VitroStudy of the Variable Effects of Proton Pump Inhibitors on VoriconazoleAntimicrobial Agents and Chemotherapy, 2015
- Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK ModelThe Korean Journal of Physiology & Pharmacology, 2015
- BDDCS Applied to Over 900 DrugsThe AAPS Journal, 2011
- Improved HPLC Method for Determination of Four PPIs, Omeprazole, Pantoprazole, Lansoprazole and Rabeprazole in Human PlasmaJournal of Pharmacy & Pharmaceutical Sciences, 2010
- Mechanistic Modeling of Hepatic Transport from Cells to Whole Body: Application to Napsagatran and FexofenadineMolecular Pharmaceutics, 2009
- Potent cytochrome P450 2C19 genotype–related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavirClinical Pharmacology & Therapeutics, 2006
- Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterionsJournal of Pharmaceutical Sciences, 2006
- COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIESDrug Metabolism and Disposition, 2004
- Effect of omeprazole on the steady‐state pharmacokinetics of voriconazoleBritish Journal of Clinical Pharmacology, 2003